Get the Stockscreener App
17.69
0.67%
-0.12
After Hours:
16.85
-0.84
-4.75%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Axogen Inc stock is traded at $17.69, with a volume of 390.91K.
It is down -0.67% in the last 24 hours and down -11.59% over the past month.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
See More
Previous Close:
$17.81
Open:
$17.57
24h Volume:
390.91K
Relative Volume:
0.75
Market Cap:
$784.44M
Revenue:
$159.01M
Net Income/Loss:
$-21.72M
P/E Ratio:
-34.02
EPS:
-0.52
Net Cash Flow:
$-20.63M
1W Performance:
-5.90%
1M Performance:
-11.59%
6M Performance:
+25.11%
1Y Performance:
+126.50%
1-Day Range:
$17.26
$17.94
1-Week Range:
$17.26
$19.33
52-Week Range:
$5.55
$21.00
Axogen Inc Stock (AXGN) Company Profile
Name
Axogen Inc
Sector
Industry
Phone
(386) 462-6817
Address
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
17.69 | 784.44M | 159.01M | -21.72M | -20.63M | -0.52 |
|
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-25 | Initiated | Lake Street | Buy |
| Jul-01-24 | Initiated | Raymond James | Outperform |
| Nov-11-22 | Resumed | Jefferies | Buy |
| May-09-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-11-22 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-07-20 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-02-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-12-19 | Initiated | Canaccord Genuity | Buy |
| Mar-02-18 | Reiterated | Lake Street | Buy |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Nov-30-17 | Initiated | Jefferies | Buy |
| Nov-21-17 | Reiterated | Lake Street | Buy |
| Jul-31-17 | Initiated | Leerink Partners | Outperform |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-17 | Initiated | ROTH Capital | Buy |
| Nov-22-16 | Upgrade | Lake Street | Hold → Buy |
| Nov-07-16 | Reiterated | Wedbush | Outperform |
| Nov-03-16 | Downgrade | Lake Street | Buy → Hold |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-14-14 | Initiated | Dawson James | Buy |
| Oct-31-13 | Reiterated | Ladenburg Thalmann | Buy |
View All
Axogen Inc Stock (AXGN) Latest News
(AXGN) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Shareholders Should Be Pleased With Axogen, Inc.'s (NASDAQ:AXGN) Price - Simply Wall St
PNC Financial Services Group Inc. Decreases Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen: LT Bullish, But Outcomes Weighted To Downside At This Point (NASDAQ:AXGN) - Seeking Alpha
Charles Schwab Investment Management Inc. Has $6.87 Million Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen appoints Rick Ditto as VP, global health economics, reimbursment & policy - TipRanks
Axogen Announces Appointment of Rick Ditto as Vice - GlobeNewswire
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Bank of New York Mellon Corp Trims Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen’s chief innovation officer sells $264,442 in shares - Investing.com India
AxoGen, Inc. (NASDAQ:AXGN) Receives $20.75 Average Target Price from Brokerages - Defense World
US Bancorp DE Makes New $30,000 Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen’s chief innovation officer sells $264,442 in shares By Investing.com - Investing.com UK
Lake Street Initiates Coverage of Axogen (LSE:0HKD) with Buy Recommendation - Nasdaq
AxoGen (NASDAQ:AXGN) Now Covered by Lake Street Capital - Defense World
Lake Street Initiates Coverage of Axogen (AXGN) with Buy Recommendation - Nasdaq
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Lake Street starts AxoGen stock with Buy, sets $30 target By Investing.com - Investing.com Canada
Axogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 75% - Yahoo Finance UK
Lake Street starts AxoGen stock with Buy, sets $30 target - Investing.com
Lake Street Initiates Axogen at Buy With $30 Price Target -March 17, 2025 at 08:17 am EDT - Marketscreener.com
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth By Investing.com - Investing.com Canada
AxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growth - Investing.com
Cantor maintains AxoGen stock target at $24, bullish on growth plan - Investing.com Australia
Cantor maintains AxoGen stock target at $24, bullish on growth plan By Investing.com - Investing.com South Africa
(AXGN) Technical Data - Stock Traders Daily
Principal Financial Group Inc. Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Cantor Fitzgerald Reaffirms “Overweight” Rating for AxoGen (NASDAQ:AXGN) - Defense World
Rhumbline Advisers Has $960,000 Stake in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen director Amy McBride sells $100,100 in stock By Investing.com - Investing.com Canada
Insider Sell: Amy Wendell Sells 5,000 Shares of Axogen Inc (AXGN) - GuruFocus.com
Axogen director Amy McBride sells $100,100 in stock - Investing.com India
Analyst Expectations For Axogen's Future - Nasdaq
Cantor Fitzgerald maintains AxoGen stock overweight rating By Investing.com - Investing.com Australia
AxoGen’s Strategic Growth and Market Positioning: Buy Rating Affirmed by Caitlin Cronin - TipRanks
Cantor Fitzgerald maintains AxoGen stock overweight rating - Investing.com India
Citizens JMP reiterates AxoGen stock with $26 target By Investing.com - Investing.com South Africa
Citizens JMP reiterates AxoGen stock with $26 target - Investing.com
14,285 Shares in AxoGen, Inc. (NASDAQ:AXGN) Bought by Y Intercept Hong Kong Ltd - Defense World
AxoGen’s Strategic Market Positioning and Anticipated BLA Approval Drive Buy Rating - TipRanks
AxoGen Unveils Strategic Priorities for 2025-2028 - TipRanks
AxoGen, Inc. (NASDAQ:AXGN) Shares Purchased by New York State Common Retirement Fund - Defense World
Leerink Partnrs Estimates AxoGen FY2029 Earnings - Defense World
Cantor Fitzgerald Decreases Earnings Estimates for AxoGen - Defense World
FY2025 EPS Estimates for AxoGen Lowered by Cantor Fitzgerald - MarketBeat
AxoGen (NASDAQ:AXGN) Posts Quarterly Earnings Results - MarketBeat
Canaccord Genuity Group Forecasts Strong Price Appreciation for AxoGen (NASDAQ:AXGN) Stock - Defense World
Axogen Inc Stock (AXGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):